• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23592 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2022     NIHR Health Technology Assessment programme Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT
2009     HAYES, Inc. Uterine artery embolization
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Uterine artery embolization for the management of uterine fibroids
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Uterine artery embolization for the treatment of fibroids
2005     HAYES, Inc. Uterine artery embolization for treatment of fibroids
2003     HAYES, Inc. Uterine artery embolization for treatment of fibroids
2002     Blue Cross Blue Shield Association (BCBS) Uterine artery embolization for treatment of symptomatic uterine fibroids
2003     Institute for Clinical Systems Improvement (ICSI) Uterine artery embolization for uterine fibroids
2001     ECRI Uterine fibroid embolization for the treatment of fibroids
2017     National Institute for Health and Care Excellence (NICE) Uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapse. NICE interventional procedures guidance 584
2019     NIHR Health Technology Assessment programme Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2019     NIHR Health Technology Assessment programme Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2002     Agency for Healthcare Research and Quality (AHRQ) Utility of blood pressure monitoring outside of the clinic setting
2017     Andalusian Health Technology Assessment Area (AETSA) Utility of exome sequencing for diagnosed dismorphic syndromes, with or without intellectual disabilities. Literature review
2008     Agency for Healthcare Research and Quality (AHRQ) Utility of monitoring mycophenolic acid in solid organ transplant patients
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Utility of MuSK antibodies in patients with myastenia gravis
2017     Andalusian Health Technology Assessment Area (AETSA) Utility of pulmonary metastases resection for colorectal cancer
2015     Andalusian Health Technology Assessment Area (AETSA) Utility of QF_PCR in prenatal diagnosis of fetal aneuploidies
2005     Institute for Clinical Evaluative Sciences (ICES) Utilization of CT and MRI scanning among cancer patients in Ontario, 1993-2002
2006     Medical Advisory Secretariat (MAS) Utilization of DXA bone mineral densitometry in Ontario: an evidence-based analysis
2005     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Utilization of information and communication technology in managing chronic diseases: a systematic review IPE-05/45 (Public report)
2003     Israel Center for Technology Assessment in Health Care (ICTAHC) Utilization patterns of CT and MRI in Israel
1994     Health Council of the Netherlands Gezondheidsraad (GR) UV radiation from sunlight
2008     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against cervical cancer
1991     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against Haemophilus influenzae type b
2009     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against pandemic influenza A/H1N1 2009: target groups and prioritisation
2004     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against pertussis
2015     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against pertussis: aims and strategy
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) Vaccination contre la grippe dans le contexte particulier de la pandémie COVID-19 : intérêt et populations prioritaires
2003     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination of children against hepatitis B
2013     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination of infants against pneumococcal infections (3)
2011     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination of young children against tuberculosis
2000     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination policies in case of an influenza pandemic
2010     NIHR Health Technology Assessment programme Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccine for herpes simplex
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccine for herpes zoster
2012     Belgian Health Care Knowledge Centre (KCE) Vaccine safety surveillance in Belgium : place and limits of a background rate approach
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccines for avian influenza
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccines for HIV
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccines for metastatic hormone-refractory prostate cancer
2015     NIHR Health Technology Assessment programme Vaccines for preventing influenza in healthy adults (A060)
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccines for prevention of human papillomavirus infection
2003     Quality Improvement Scotland (NHS QIS ) Vacuum assisted closure (VAC) for wound healing
2004     Medical Advisory Secretariat (MAS) Vacuum assisted closure therapy for wound care
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vacuum assisted wound closure therapy
2006     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Vacuum-assisted breast biopsy
2003     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Vacuum-assisted closure for the management of wounds: an accelerated systematic review
2000     ECRI Vacuum-assisted wound closure for chronic and acute wounds
2005     Technology Assessment Unit of the McGill University Health Centre (MUHC) Vacuum-assisted wound closure therapy (V.A.C (R))
2003     Agency for Healthcare Research and Quality (AHRQ) Vaginal birth after Cesarean (VBAC)
2010     Agency for Healthcare Research and Quality (AHRQ) Vaginal birth after cesarean: new insights
1993     Danish Institute for Health Services Research (DSI) Vaginal bleeding disorders. Consensus statement
2010     Adelaide Health Technology Assessment (AHTA) Vaginal brachytherapy for treatment of women with high-intermediate risk of endometrial cancer
2000     HAYES, Inc. Vaginal hormonal cytology for the diagnosis and management of menopause
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vaginal micronized progesterone capsules for the prevention of miscarriage and preterm birth: a review of the clinical evidence
2021     Ontario Health Vaginal pessaries for pelvic organ prolapse and stress urinary incontinence
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Vaginal preparation prior to cesarean delivery: clinical evidence
2023     National Institute for Health and Care Excellence (NICE) Vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditions. NICE interventional procedures guidance 774
1997     Alberta Heritage Foundation for Medical Research (AHFMR) Vaginoplasty in male-female transsexuals and criteria for sex reassignment surgery
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Vagus nerve blocking and gastric artery embolisation for obesity
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Vagus nerve stimulation
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vagus nerve stimulation (VNS) for treatment-resistant depression
2018     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Vagus nerve stimulation for chronic major depressive episodes
2018     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Vagus nerve stimulation for chronic major depressive episodes
2009     HAYES, Inc. Vagus nerve stimulation for depression
2005     HAYES, Inc. Vagus nerve stimulation for depression
2013     HAYES, Inc. Vagus nerve stimulation for depression
2009     HAYES, Inc. Vagus nerve stimulation for depression
2008     Adelaide Health Technology Assessment (AHTA) Vagus nerve stimulation for epilepsy
2009     HAYES, Inc. Vagus nerve stimulation for epilepsy
2008     Medical Services Advisory Committee (MSAC) Vagus nerve stimulation for epilepsy
2003     HAYES, Inc. Vagus nerve stimulation for epilepsy
2007     HAYES, Inc. Vagus nerve stimulation for epilepsy
2014     HAYES, Inc. Vagus nerve stimulation for epilepsy
1998     Alberta Heritage Foundation for Medical Research (AHFMR) Vagus nerve stimulation for refractory epilepsy
2001     Alberta Heritage Foundation for Medical Research (AHFMR) Vagus nerve stimulation for refractory epilepsy
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Vagus Nerve Stimulation for refractory epilepsy
2001     Alberta Heritage Foundation for Medical Research (AHFMR) Vagus nerve stimulation for refractory epilepsy
2004     National Institute for Health and Care Excellence (NICE) Vagus nerve stimulation for refractory epilepsy in children. NICE interventional procedures guidance 50
1998     ECRI Vagus nerve stimulation for the treatment of intractable epilepsy
2006     Blue Cross Blue Shield Association (BCBS) Vagus nerve stimulation for treatment-resistant depression
2005     Blue Cross Blue Shield Association (BCBS) Vagus nerve stimulation for treatment-resistant depression
1998     Wessex Institute for Health Research and Development (WIHRD) Vagus nerve stimulation in epilepsy
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Vagus nerve stimulation therapy
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Vagus nerve stimulation therapy
2022     Agency for Care Effectiveness (ACE) Vagus nerve stimulation with the VITARIA System for heart failure with reduced ejection fraction
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vagus nerve stimulator (VNS)
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Valdecoxib
2008     HAYES, Inc. Valerian for treatment of insomnia
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Valganciclovir (Valcyte®) powder for oral solution
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Valganciclovir (Valcyte®) tablets
2020     NIHR Health Technology Assessment programme Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis
2002     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Validation: dementia in elder people - primary research
2002     Centre for Clinical Effectiveness (CCE) Validity of the venous thromboembolism risk factor assessment model as described by Motykie et al (2000)
2020     Institute for Clinical and Economic Review (ICER) Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Valsartan (Diovan®)
2023     Institute for Clinical and Economic Review (ICER) Value assessment framework
2014     University of York Value based commissioning of MSK Procedures: an appraisal of the evidence for the proposed policies
1994     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Value of echoendoscopy in gastrointestinal disease
2007     Haute Autorite de sante (HAS) Value of extra-cranial stereotactic radiotherapy